Form 4 for ADMA ADMA BIOLOGICS, INC.
Accepted 2026-05-28 16:05:25 ET · period of report 2026-05-27 · accession 0001140361-26-023127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-28 16:05 | 2026-05-27 | ADMA | Grossman Jerrold B | Dir | P - Purchase | $7.91 | +6,400 | 520.3K | +1% | +$50.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-27 | P | A | 6,400 | $7.91 | 520,284 | D | — | — | (F1) Represents an open market purchase in a single transaction. (F2) Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, half of which will vest on August 9, 2026, and the other half of which will vest on February 9, 2027, subject to the Reporting Person's continued service as of each such vesting date; and (ii) 509,594 shares of common stock owned by the Reporting Person. |